Link to “Insights” webpage: www.TIRF-Labs.com/insights/
i-Diagnostics Insights: TIRF Labs develops a global project described at the URL: i-Diagnostics.net, which goal is to prevent the emergence and minimize the outbreaks of diseases. We have developed and supplied laboratory versions of i-Diagnostics to several research groups and pledged to make i-Diagnostics an open source platform suitable for a global infrastructure of precision medicine so that accurate diagnostics will be available to everyone. Please forward the link www.i-diagnostics.net to philanthropists. We invite you to donate and become a part of global efforts to stop current and prevent future pandemics, revolutionize medicine, improve quality, and reduce the cost of healthcare.
We welcome you to share your opinions and ideas about emerging and propagating pandemics. The COVID-19 crisis has demonstrated that we need a global infrastructure, which would help to prevent, localize and combat pandemics.
Scientific and technological capabilities for efficient management of pandemics already exist. Scientists and medical professionals have outlined the necessary measures on COVID-19 in the Great Barrington Declaration and in the Open Letter of Belgian Medical Doctors.
Unfortunately, there is a large gap between science, mass media and decision-making politicians. Safety of biological materials for human use, including vaccines and drugs, must be the highest priority in all circumstances. If adverse side-effects and multiple deaths are reported, the biological material must be removed from the market, without any delay.
The development of new vaccines, even if the pathogen does not mutate, in principle, cannot be fast. Long-term side effects of genetic materials injected into human body are impossible to predict. Therefore, alternative approach – re-purposing of previously approved drugs (approved for other purposes) to combat new pathogens – appears to be a productive method, which has proven its efficiency in numerous instances over several decades. The State of Nebraska is the first U.S. state, which approved Ivermectin as COVID-19 treatment.
Ivermectin
For details visit the webpage www.TIRF-Labs.com/insights/